Paper Details

  1. Home
  2. Paper Details

Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa.

Author: BellaisSamuel, JacolotAnne, LéotardSophie, MimozOlivier, NordmannPatrice, PetitjeanOlivier

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study examines the efficacy of various antibiotics against a Pseudomonas aeruginosa strain producing VIM-2 carbapenemase in a rat pneumonia model. Imipenem, cefepime, ceftazidime, piperacillin-tazobactam, and aztreonam show effectiveness at high doses, despite their high MICs.
Paper Details　
Original Abstract of the Article :
A rat pneumonia model was established with a Pseudomonas aeruginosa strain that produced the plasmid-encoded metallocarbapenemase VIM-2. A significant decrease in lung bacterial titers was observed when imipenem, cefepime, ceftazidime, and piperacillin-tazobactam were given at the highest doses reco...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1128/AAC.46.6.2032-2034.2002

データ提供：米国国立医学図書館（NLM）

Efficacy of Beta-Lactams for Treating Experimentally Induced Pneumonia

Pneumonia, a serious lung infection, is like a desert sandstorm that can overwhelm the respiratory system. This study investigates the efficacy of beta-lactam antibiotics against experimentally induced pneumonia caused by a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa. Researchers aimed to determine the effectiveness of these antibiotics in combating this drug-resistant bacterial infection.

Battling Drug Resistance: Finding a Weapon in the Desert

The study found that certain beta-lactams, even at high doses, were effective in reducing bacterial titers in the lungs of infected rats. This suggests that these antibiotics may still have a role to play in the treatment of pneumonia caused by this drug-resistant strain. It's like discovering a hidden spring in the desert, a source of hope in the face of antibiotic resistance.

Navigating the Challenges of Antibiotic Resistance

The study highlights the ongoing challenges of antibiotic resistance. It underscores the need for continued research to develop new antibiotics and strategies for combating drug-resistant bacteria. It's like exploring a vast desert, searching for new resources and pathways to overcome the threat of antibiotic resistance.

Dr.Camel's Conclusion

This study offers a glimmer of hope in the fight against antibiotic resistance. The findings suggest that certain beta-lactams may still be effective against drug-resistant bacteria, but continued research is crucial to develop new strategies for combating this growing challenge. As we navigate the desert of antibiotic resistance, we must remain vigilant and seek innovative solutions to protect our health.

Date :
  1. Date Completed 2002-10-22
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

12019134

DOI: Digital Object Identifier

10.1128/AAC.46.6.2032-2034.2002

Related Literature

Article Analysis
・Effects of aztreonam injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.